Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
requiring invasive mechanical ventilation
Must not have
Timeline
Screening 3 weeks
Treatment Varies
Follow Upfrom date of intubation until the date of death from any cause, whichever came first, assessed up to 4 months
Awards & highlights
No Placebo-Only Group
VIREM Trial Summary
This trial will study the effects of a patient's inspiratory effort on their lungs and diaphragm.
Eligible Conditions
- Respiratory Function Tests
- Respiratory Muscles
- Artificial Respiration
VIREM Trial Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowVIREM Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from date of intubation until the date of death from any cause, whichever came first, assessed up to 4 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from date of intubation until the date of death from any cause, whichever came first, assessed up to 4 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Tidal esophageal pressure swing (∆Pes) - D1
Tidal esophageal pressure swing (∆Pes) - D2
Tidal esophageal pressure swing (∆Pes) - D3
+5 moreSecondary outcome measures
Dead space ventilation (VD) - D1
Dead space ventilation (VD) - D2
Continuous Positive Airway Pressure
+87 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
VIREM Trial Design
1Treatment groups
Experimental Treatment
Group I: Overall groupExperimental Treatment1 Intervention
Placement of a nasogastric balloon
Find a Location
Who is running the clinical trial?
KU LeuvenOTHER
532 Previous Clinical Trials
200,339,076 Total Patients Enrolled
Universitaire Ziekenhuizen LeuvenOTHER
849 Previous Clinical Trials
1,244,123 Total Patients Enrolled
University Hospital, AntwerpLead Sponsor
279 Previous Clinical Trials
112,871 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Overall group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any openings left to participate in this clinical research?
"Affirmative. According to clinicaltrials.gov, this medical trial which was initially advertised on September 21st 2022 is currently recruiting participants. Approximately 150 patients need to be enrolled from a single site."
Answered by AI
What is the participant quota for this research experiment?
"Affirmative. The information hosted on clinicaltrials.gov suggests that this research project, which was first posted on September 21st 2022, is in the process of participant recruitment. 150 people are required to join from a single site."
Answered by AI
Share this study with friends
Copy Link
Messenger